Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
16.66
+0.58 (3.63%)
Nov 21, 2024, 11:19 AM EST - Market open
CRBP Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 203 | 27 | 14 | 77 | 105 | 353 | |
| Market Cap Growth | 733.34% | 93.01% | -82.05% | -26.60% | -70.25% | 5.64% | |
| Enterprise Value | 40 | 21 | -27 | -4 | 49 | 307 | |
| Last Close Price | 16.08 | 6.04 | 3.32 | 18.47 | 37.50 | 163.80 | |
| PS Ratio | - | - | - | 87.45 | 26.68 | 9.77 | |
| PB Ratio | 1.30 | -3.87 | 0.42 | 1.12 | 2.32 | 57.35 | |
| P/TBV Ratio | 1.65 | - | 0.42 | 1.12 | 2.32 | 57.35 | |
| EV/Sales Ratio | - | - | - | - | 12.54 | 8.48 | |
| Debt / Equity Ratio | 0.02 | -3.02 | 0.76 | 0.38 | 0.59 | 1.53 | |
| Asset Turnover | - | - | - | 0.01 | 0.05 | 0.75 | |
| Quick Ratio | 13.71 | 0.66 | 4.68 | 5.74 | 2.76 | 0.99 | |
| Current Ratio | 13.84 | 0.74 | 4.76 | 5.89 | 2.89 | 1.09 | |
| Return on Equity (ROE) | -51.32% | -341.98% | -82.95% | -79.80% | -432.68% | -424.29% | |
| Return on Assets (ROA) | -28.82% | -59.57% | -25.02% | -33.32% | -101.37% | -100.26% | |
| Return on Capital (ROIC) | -32.59% | -78.19% | -28.32% | -41.71% | -175.01% | -221.45% | |
| Earnings Yield | -19.76% | -166.93% | -305.90% | -59.19% | -105.92% | -20.24% | |
| FCF Yield | -18.82% | -135.11% | -271.30% | -62.56% | -95.36% | -13.72% | |
| Buyback Yield / Dilution | -110.46% | -3.76% | -1.85% | -57.23% | -22.28% | -12.10% | |
| Total Shareholder Return | -110.46% | -3.76% | -1.85% | -57.23% | -22.28% | -12.10% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.